Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuan Tu
Observed names:
TU Yuan,
Yuan TU
Institutions:
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Chongqing Medical University
Observed institutions:
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Chongqing Medical University
ORCID:
0000-0002-9800-4637
Observed ORCID:
0000-0002-9800-4637
OpenAlex ID:
A5055348444
Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma
2021
·
Peng Jiang
, Yuzhen Huang
, et al.
·
Frontiers in Oncology
·
26
PDF
Incidence, risk factors, and a prognostic nomogram for distant metastasis in endometrial cancer: A SEER‐based study
2023
·
Yunfeng Zheng
, Peng Jiang
, et al.
·
International Journal of Gynecology & Obstetrics
·
24
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer
2023
·
Jinyu Wang
, Peng Jiang
, et al.
·
American Journal of Clinical Oncology
·
24
Identification and validation of long non-coding RNA associated ceRNAs in intrauterine adhesion
2021
·
Jingni Zhang
, Peng Jiang
, et al.
·
Bioengineered
·
15
The positive threshold of the immunohistochemical parameter Ki67 for predicting the recurrence of cervical cancer
2021
·
Yuan Tu
, Peng Jiang
, et al.
·
International Journal of Gynecology & Obstetrics
·
14
Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer
2022
·
Ning Li
, Peng Jiang
, et al.
·
Clinical Medicine Insights Oncology
·
9
PDF
YAP1 affects the prognosis through the regulation of stemness in endometrial cancer
2023
·
Wei Kong
, Yuzhen Huang
, et al.
·
PeerJ
·
8
Nomogram Incorporating Inflammatory Index, Pathology, and Molecular Classification for Predicting Recurrence in Patients with Stage I-III Endometrial Cancer: A Multi-Institutional Study
2025
·
Yao Xiao
, Yunfeng Zheng
, et al.
·
Journal of Inflammation Research
·
7
PDF
Prognostic significance and immune infiltration analysis of HMGA2 in endometrial cancer
2025
·
Peng Jiang
, Jiaxin Yu
, et al.
·
Frontiers in Immunology
·
7
Significance of the Number of Intermediate-Risk Factors in Cervical Cancer Patients Treated with Radical Hysterectomy: A Retrospective Study of 976 Patients
2021
·
Jingni Zhang
, Peng Jiang
, et al.
·
Journal of Investigative Surgery
·
6
Comprehensive Assessment of ERα, PR, Ki67, P53 to Predict the Risk of Lymph Node Metastasis in Low-Risk Endometrial Cancer
2022
·
Yuzhen Huang
, Peng Jiang
, et al.
·
Journal of Investigative Surgery
·
5
Nomogram Based on Pan-Immune Inflammation Value and Clinicopathological Parameters for Predicting the Recurrence of Endometrial Cancer and Providing Postoperative Prognostic Management
2025
·
Jiaojiao Long
, Chengfan Tian
, et al.
·
Annals of Surgical Oncology
·
4
Effect of Number of Retrieved Lymph Nodes on Prognosis in FIGO Stage IA1-IIA2 Cervical Cancer Patients Treated With Primary Radical Surgery
2022
·
Shan Jiang
, Peng Jiang
, et al.
·
Clinical Medicine Insights Oncology
·
4
Consistency of P53 immunohistochemical expression between preoperative biopsy and final surgical specimens of endometrial cancer
2023
·
Jun Zhang
, Peng Jiang
, et al.
·
Frontiers in Oncology
·
3
The prognostic significance of JAML and its role in remodeling the immune microenvironment via the cGAS-STING pathway in endometrial cancer
2026
·
Chenfan Tian
, Yuanyang Yao
, et al.
·
Frontiers in Immunology
·
2
A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with endometrial cancer
2022
·
Yuan Tu
, Peng Jiang
, et al.
·
Research Square
·
2
PDF
Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer
2022
·
Wei Kong
, Yuan Tu
, et al.
·
The International Journal of Biological Markers
·
2
A Metabolic‐Epigenetic Axis of AARS1/IGF2BP3‐K280 Lactylation Sustains Endometrial Cancer Stemness and Recurrence
2026
·
Peng Jiang
, Yunfeng Zheng
, et al.
·
Advanced Science
·
1
A nomogram integrating YTHDC2 expression and clinicopathological parameters for predicting endometrial cancer recurrence: a multicenter retrospective study
2026
·
Yu Gong
, Lamei Hou
, et al.
·
Frontiers in Oncology
PDF
AKNA serves as a prognostic biomarker and restrains endometrial cancer progression via STING activation and macrophage reprogramming
2026
·
Yuan Tu
, Lingya Xu
, et al.
·
Frontiers in Immunology
PDF
Prognostic nomogram incorporating dynamic SIRI score and clinical parameters to predict postoperative recurrence of endometrial cancer
2026
·
Yunfeng Zheng
, Peng Jiang
, et al.
·
Scientific Reports
PDF
A Novel Nomogram Incorporating the Aggregate Index of Systemic Inflammation, Clinicopathological Parameters and Molecular Classification to Predict Recurrence of Endometrial Cancer: A Multi‐Center Retrospective Study
2026
·
Chenfan Tian
, Na Zeng
, et al.
·
Cancer Medicine
Predictive value of IGF2BP2 for endometrial cancer recurrence: a multicenter study
2026
·
Jie Xiong
, Peng Jiang
, et al.
·
Frontiers in Oncology
PDF
Identification and validation of long non-coding RNA associated ceRNAs in intrauterine adhesion
2021
·
Jingni Zhang
, Peng Jiang
, et al.
·
Figshare
Show more works
View as search
Works count:
25
Citation count:
163
H-index:
7
I10-index:
5
Year
Topic
Type